scholarly article | Q13442814 |
P50 | author | James C. Hogg | Q17517107 |
P2093 | author name string | Chun Liu | |
Timothy Z Vitalis | |||
Shizu Hayashi | |||
W Mark Elliott | |||
Xiang-Dong Wang | |||
Diana Ionescu | |||
Bernard Meshi | |||
P2860 | cites work | Structural and inflammatory changes in COPD: a comparison with asthma | Q35563928 |
Adenovirus E1A gene dysregulates ICAM-1 expression in transformed pulmonary epithelial cells | Q41142726 | ||
Immunodetection of adenoviral E1A proteins in human lung tissue | Q41338542 | ||
Latent adenoviral infection in the pathogenesis of chronic airways obstruction | Q44702557 | ||
Amplification of inflammation in emphysema and its association with latent adenoviral infection | Q44764238 | ||
A model of latent adenovirus 5 infection in the guinea pig (Cavia porcellus). | Q46179443 | ||
A quantification of the lung surface area in emphysema using computed tomography. | Q52223048 | ||
Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. | Q53427307 | ||
P433 | issue | 1 | |
P921 | main subject | Adenoviridae | Q193447 |
inflammation | Q101991 | ||
P304 | page(s) | 52-57 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
P1476 | title | Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response | |
P478 | volume | 26 |
Q46845453 | A noninvasive [99mTc]DTPA SPECT/CT imaging methodology as a measure of lung permeability in a guinea pig model of COPD. |
Q42134462 | Acute respiratory infection with mouse adenovirus type 1 |
Q40696211 | Adenoviral E1A modulates inflammatory mediator expression by lung epithelial cells exposed to PM10. |
Q39900973 | Adenovirus E1A regulates lung epithelial ICAM-1 expression by interacting with transcriptional regulators at its promoter |
Q36796501 | Adenovirus infections and lung disease |
Q36602291 | Alveolar macrophages as orchestrators of COPD. |
Q57979716 | Association of Chronic Obstructive Pulmonary Disease Severity andPneumocystisColonization |
Q35990449 | Association of TNF-α -308G/A, SP-B 1580 C/T, IL-13 -1055 C/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population |
Q34905929 | Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema |
Q36634735 | Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema |
Q93013037 | Diminished stimulator of interferon genes production with cigarette smoke-exposure contributes to weakened anti-adenovirus vectors response and destruction of lung in chronic obstructive pulmonary disease model |
Q55384969 | Dysregulated Functions of Lung Macrophage Populations in COPD. |
Q33364556 | Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice |
Q37448511 | Eosinophil and T cell markers predict functional decline in COPD patients |
Q52573931 | Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals. |
Q37343878 | FGF signaling is required for myofibroblast differentiation during alveolar regeneration |
Q34998846 | Hepatitis C virus infection is not an independent risk factor for obstructive lung disease. |
Q37950974 | Human bocavirus-the first 5 years |
Q36438868 | Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. |
Q35085363 | Implications of the innate immune response to adenovirus and adenoviral vectors |
Q35897669 | Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer |
Q44103428 | Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells |
Q36278163 | Innate immune response to adenovirus |
Q34637544 | Latent adenovirus infection in COPD. |
Q22305860 | Lung microbiology and exacerbations in COPD |
Q44495192 | Lung retinol storing cells synthesize and secrete retinoic acid, an inducer of alveolus formation |
Q35790735 | Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy |
Q37068538 | Mechanisms of cigarette smoke-induced COPD: insights from animal models |
Q26786359 | Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond |
Q24798450 | Models of chronic obstructive pulmonary disease |
Q37809217 | Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance |
Q33660664 | Neutrophilic Inflammation in the Immune Responses of Chronic Obstructive Pulmonary Disease: Lessons from Animal Models. |
Q34778056 | Neutrophilic airway inflammation and IL-17. |
Q37901388 | New respiratory viruses and the elderly |
Q38679715 | Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians |
Q35665638 | Novel aspects of pathogenesis and regeneration mechanisms in COPD |
Q34684239 | Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations |
Q37236161 | Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease |
Q39804008 | Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease |
Q36368544 | Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes |
Q36804180 | Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice |
Q37014972 | Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease? |
Q35087147 | Pulmonary toxicity of chronic exposure to tobacco and biomass smoke in rats |
Q39118441 | Respiratory Viral Infections in Chronic Lung Diseases |
Q35536577 | Retinoic acid fails to reverse emphysema in adult mouse models |
Q35879309 | Retinoids in lung development and regeneration |
Q35069037 | Retinoids, alveolus formation, and alveolar deficiency: clinical implications |
Q57043148 | S100A8 Protects Human Primary Alveolar Type II Cells Against Injury and Emphysema |
Q35593935 | SCGB3A2 Inhibits Acrolein-Induced Apoptosis through Decreased p53 Phosphorylation |
Q36640817 | Second hand smoke and COPD: lessons from animal studies. |
Q46438938 | Short-term cigarette smoke exposure enhances allergic airway inflammation in mice |
Q36167843 | Similarities and dissimilarities of branching and septation during lung development |
Q37184739 | Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract |
Q59130095 | The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable |
Q38538384 | The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi). |
Q36669465 | The challenges of chronic obstructive pulmonary diseases (COPD)--a perspective |
Q39200222 | The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. |
Q38060647 | Therapeutic potential of growth factors in pulmonary emphysematous condition. |
Q36634739 | Toward therapeutic pulmonary alveolar regeneration in humans |
Q37157003 | Using guinea pigs in studies relevant to asthma and COPD. |
Q34197136 | Viruses exacerbating chronic pulmonary disease: the role of immune modulation. |
Q36763151 | Vitamin A and emphysema |
Q36745629 | β-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice |
Search more.